Veracyte Has Released Our Inaugural ESG Report READ NOW
Search Tool Menu
Veracyte Has Released Our Inaugural ESG Report READ NOW
Menu
Close Button
Afirma Patient Afirma Patient
Afirma Patient
Top Places To Work 2022
What made the difference?
As a 23 year old, hearing the words, "You might have cancer," is terrifying. My doctor gave me an option of having my thyroid removed to get a clearer diagnosis. With the Afirma test I had a benign result and was able to avoid surgery. I felt a great sense of relief and confidence in the test. Grateful for the outcome.
Real People
Knowing
Real Answers.
ASHLEY BUNCH
Afirma Patient
Know by
our impact
LATEST NEWS
New data presented at ASTRO 2021 validate prognostic ability of Decipher Prostate genomic classifier
learn more >
LATEST NEWS
Veracyte unveils expanded clinical validation data for noninvasive nasal swab test to improve early lung cancer risk assessment
learn more >
WATCH
Bonnie Anderson, cofounder and executive chairwoman, on what it takes to make a meaningful and lasting impact on cancer diagnostics



Our Products
latest news